Related Experiment Video
Updated: May 21, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Universal rapid screening for methicillin-resistant Staphylococcus aureus in the intensive care units in a large
Rebecca Kjonegaard1, Willa Fields, K Michael Peddecord
1Sharp Healthcare, San Diego, CA, USA. Rebecca.Kjonegaard@sharp.com
Background:
Health care-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) infections constitute a significant risk for hospitalized patients. This study evaluates the costs and effects of comprehensive and state-mandated MRSA screening for intensive care unit (ICU) patients and subsequent contact precautions on the rate of HA-MRSA.
Methods:
A pre- and postimplementation study was conducted in a 24-bed medical intensive care unit (MICU) and a 15-bed surgical intensive care unit (SICU) at an acute care 536-bed community hospital. This study used computerized records for all patients admitted to ICUs. Costs were estimated from financial records.
Results:
HA-MRSA infection rates did not decline after implementation of ICU screening. Regression analysis demonstrated that patients admitted from skilled nursing facilities, assisted living, and similar facilities were 12 times more likely to screen positive for MRSA as compared with patients admitted from home. The costs to identify each MRSA positive patient were $1,650 and $953 for comprehensive and state-mandated periods, respectively.
Conclusion:
In low prevalence hospitals without MRSA outbreaks, it is recommended that MRSA screening be conducted on patients admitted from skilled nursing and similar facilities because they are most likely to be colonized with MRSA. Results do not support mandates to conduct screening on all patients admitted to critical care units.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) screening in intensive care units (ICUs) did not reduce infection rates. Screening is most cost-effective for patients from skilled nursing facilities, not all ICU admissions.
Area of Science:
- Infectious Disease Epidemiology
- Healthcare-Associated Infections
- Public Health Policy
Background:
- Health care-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) poses a significant risk to hospitalized patients.
- This study assessed the impact of MRSA screening and contact precautions on HA-MRSA rates.
Purpose of the Study:
- To evaluate the cost-effectiveness of comprehensive and state-mandated MRSA screening for intensive care unit (ICU) patients.
- To determine the effect of screening and contact precautions on HA-MRSA rates.
Main Methods:
- A pre- and postimplementation study design was used in medical and surgical ICUs.
- Computerized records and financial data were utilized to analyze patient admissions and costs.
Main Results:
- HA-MRSA infection rates did not decrease following the implementation of ICU screening.
- Patients from skilled nursing and assisted living facilities were 12 times more likely to screen positive for MRSA.
- The cost per identified MRSA-positive patient was $1,650 (comprehensive) and $953 (state-mandated).
Conclusions:
- MRSA screening is recommended for patients admitted from skilled nursing facilities in low-prevalence hospitals without outbreaks.
- Mandatory screening for all ICU admissions is not supported by these findings.
- Targeted screening can optimize resource allocation in infection control.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Automated Microbial Diagnostics
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Urine Studies II: Urine Culture and Sensitivity Test
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
